Mistral AI CEO: Nvidia partnership 'super meaningful' — Positive

NVDA   CNBC International TV — June 13, 2025

The partnership with Nvidia allows Mistral AI to "go faster and offer the best services," according to Mistral's Co-Founder and CEO Arthur Mensch, who spoke to CNBC at the VivaTech conference in Paris.

image for news Mistral AI CEO: Nvidia partnership 'super meaningful'

SAN DIEGO, June 13, 2025 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Red Cat Holdings, Inc. (NASDAQ: RCAT) securities between March 18, 2022 and January 15, 2025, both dates inclusive (the “Class Period”), have until Tuesday, July 22, 2025 to seek appointment as lead plaintiff of the Red Cat class action lawsuit. Captioned Olsen v. Red Cat Holdings, Inc., No. 25-cv-05427 (D.N.J.), the Red Cat class action lawsuit charges Red Cat and certain of Red Cat's top current and former executives with violations of the Securities Exchange Act of 1934.

image for news INVESTOR DEADLINE: Red Cat Holdings, Inc. (RCAT) Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit

Tesla raises price of refreshed Model S and Model X vehicles — Neutral

TSLA   Proactive Investors — June 13, 2025

Tesla Inc (NASDAQ:TSLA) has refreshed its flagship Model S and Model X vehicles in the US, with minor design and performance updates resulting in a $5,000 price increase across all trims. Prices for the Model S now start at $84,990 for the Long Range version and $99,990 for the high-performance Plaid.

image for news Tesla raises price of refreshed Model S and Model X vehicles

OpenAI to continue working with Scale AI after Meta deal — Neutral

META   Reuters — June 13, 2025

OpenAI plans to continue working with Scale AI after rival Meta on Friday agreed to take a 49% stake in the artificial intelligence startup for $14.8 billion, OpenAI's CFO Sarah Friar told the VivaTech conference in Paris.

image for news OpenAI to continue working with Scale AI after Meta deal

Some Undervalued Tech Stocks Reside in This ETF — Positive

QQQJ   ETF Trends — June 13, 2025

The Magnificent Seven stocks propelled the Nasdaq-100 Index (NDX) to a gain of 3.46% for the month ending June 12. And that gauge has risen by nearly 14% over the past 90 days.

image for news Some Undervalued Tech Stocks Reside in This ETF

Here's Why You Should Retain AMED Stock in Your Portfolio for Now — Positive

AMED   Zacks Investment Research — June 13, 2025

Amedisys' high Quality of Patient Care and Patient Satisfaction star ratings bring optimism to investors. Yet, a dull macroeconomic condition adds to the worry.

image for news Here's Why You Should Retain AMED Stock in Your Portfolio for Now

Can CEG's Nuclear Power Keep Up With AI-Driven Data Center Demand? — Positive

CEG   Zacks Investment Research — June 13, 2025

CEG surges 43.2% in 3 months as it taps nuclear power to fuel rising AI data center demand with long-term deals.

image for news Can CEG's Nuclear Power Keep Up With AI-Driven Data Center Demand?

Can Twilio's Cross-Sell Strategy Unlock Higher Profitability? — Positive

TWLO   Zacks Investment Research — June 13, 2025

Twilio aims to boost profit through cross-selling, with large customers rising 37% in the first quarter.

image for news Can Twilio's Cross-Sell Strategy Unlock Higher Profitability?

Great Lakes Stock Trading at a Discount: Is It Buy Time Now? — Positive

GLDD   Zacks Investment Research — June 13, 2025

Great Lakes Dredge & Dock Corporation's GLDD current valuation is enticing for investors. Currently, the stock is trading below its industry peers with a forward 12-month price-to-earnings (P/E) ratio of 12.43X, as evidenced by the chart below.

image for news Great Lakes Stock Trading at a Discount: Is It Buy Time Now?

Options Corner: META's Mega A.I. Investment — Positive

META   Schwab Network — June 13, 2025

@ProsperTradingAcademy's Scott Bauer says Meta Platforms (META) is a stock to "buy the dip" on any pullback, saying it continues to build its position in A.I. META announced a $14.3B investment into Scale AI as Mark Zuckerberg aims to create a superintelligence lab.

image for news Options Corner: META's Mega A.I. Investment

Buy, Sell, Or Hold Boeing Stock At $200? — Negative

BA   Forbes — June 13, 2025

Boeing (NYSE:BA) declined by 5% on Thursday, June 12, following the devastating crash of an Air India 787 Dreamliner, resulting in the death of 241 individuals. Although the 787 is generally regarded as a very safe aircraft, Boeing has encountered considerable scrutiny and penalties over the past year due to ongoing quality control problems, especially regarding its 737 MAX fleet.

image for news Buy, Sell, Or Hold Boeing Stock At $200?

Israel Attacks Iran Sending Oil Prices Higher — Negative

BNO  DBO  GUSH  IEO  OIH  OIL  PXJ  UCO  USO  XOP   Forbes — June 13, 2025

Key Takeaways

image for news Israel Attacks Iran Sending Oil Prices Higher

Will Adobe Stock See Higher Levels? — Positive

ADBE   Forbes — June 13, 2025

Adobe (NASDAQ:ADBE) recently revealed its Q2 results (fiscal year ending in November), exceeding analyst expectations. The firm reported earnings of $5.06 per share on revenues of $5.9 billion, surpassing the consensus estimates of $4.97 per share and $5.8 billion, respectively.

image for news Will Adobe Stock See Higher Levels?

NEW YORK CITY, NY / ACCESS Newswire / June 13, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Capricor Therapeutics, Inc. ("Capricor" or the "Company") (NASDAQ:CAPR). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

image for news INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Capricor Therapeutics, Inc. - CAPR

LEHIGH VALLEY, Pa. , June 13, 2025 /PRNewswire/ -- Air Products (NYSE:APD) will showcase industrial gas solutions and technologies for metals and materials processing applications at the PowderMet2025 International Conference on Powder Metallurgy and Particulate Materials from June 15-18 at the Sheraton Phoenix Downtown in Phoenix, Arizona.

image for news Air Products to Showcase Industrial Gas Solutions at the PowderMet2025 International Conference on Powder Metallurgy and Particulate Materials

NEW YORK CITY, NY / ACCESS Newswire / June 13, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Globus Medical, Inc. ("Globus" or the "Company") (NYSE:GMED). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

image for news INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Globus Medical, Inc. - GMED

NEW YORK CITY, NY / ACCESS Newswire / June 13, 2025 / Pomerantz LLP is investigating claims on behalf of investors of ADTRAN Holdings, Inc.("ADTRAN" or the "Company") (NASDAQ:ADTN). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

image for news INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADTRAN Holdings, Inc. - ADTN

NEW YORK CITY, NY / ACCESS Newswire / June 13, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Metallus Inc. ("Metallus" or the "Company") (NYSE:MTUS). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

image for news INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Metallus Inc. - MTUS

NEW YORK CITY, NY / ACCESS Newswire / June 13, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Cable One, Inc. ("Cable One" or the "Company") (NYSE:CABO). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

image for news INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cable One, Inc. - CABO

BOULDER, Colo. , June 13, 2025 /PRNewswire/ -- Enliven Therapeutics, Inc. (Enliven or the Company) (Nasdaq: ELVN), a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics, today announced that it has priced its previously announced underwritten public offering of 8,394,737 shares of its common stock at a price to the public of $19.66 per share and, in lieu of common stock to investors who so choose, pre-funded warrants to purchase up to 1,780,263 shares of Enliven's common stock at a price to the public of $19.659 per pre-funded warrant, which represents the per share public …

image for news Enliven Therapeutics Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants